BioWorld Asia

Dec. 31, 2008

View Archived Issues

Finally Something Positive! Two UK Investor Funds Close

LONDON - There may be signs of life yet in biotech investing. (BioWorld International) Read More

EMEA 2009 Plan Includes More Help for the Industry

Human Blood Cancers Highlight New Approach to Therapies

UK Company Points Way to More Predictive Rat Models

NicOx/Topigen Discontinue COPD Work on TPI 1020

Paladin Labs Acquires ViRexx with Bankruptcy Financing

Other News To Note

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...